Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Kelly Rouster-Stevens

Biographic Data

ID10404682
NAMEKelly Rouster-Stevens
GIVEN NAMESKelly
FAMILY NAMERouster-Stevens
SIGNATUREROUSTER-STEVENS K
AFFILIATIONSDivision of Pediatric Rheumatology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA
VERIFIEDNo
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2022
LATEST PUBLICATION YEAR2023
H-INDEX0
  • Improving Hepatitis B Screening Prior to Rituximab

    Open Access•D Sofia Villacis-Nunez, Evan Orenstein et al.•ARTICLE•Children•2023

    Rituximab, used in the treatment of some rheumatic and kidney diseases, can lead to hepatitis B virus (HBV) reactivation; HBV screening is recommended for those starting this medication. We aimed to improve by 50% the proportion of patients undergoing HBV screening by implementing multimodal interventions to support clinicians in this evidence-based practice. We conducted a quality improvement project from November 2020 to June 2022 at a tertiary…

  • Clinical Determinants of Childhood Onset Systemic Lupus Erythematosus among Early and Peri-Adolescent Age Groups

    Open Access•Meghan Corrigan Nelson, Shanmuganathan Chandrakasan et al.•ARTICLE•Children•2022

    Introduction: Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that is associated with significant morbidity and mortality. SLE disproportionately affects women and minorities. Childhood-onset SLE (cSLE) in particular tends to be more aggressive than adult-onset SLE. Despite substantial improvements in the treatment of cSLE, there is significant variability in treatment responses and long-term outcomes. Furthermore, there is…

No prominent works on this page.

  • Clinical Determinants of Childhood Onset Systemic Lupus Erythematosus among Early and Peri-Adolescent Age Groups

    Open Access•Meghan Corrigan Nelson, Shanmuganathan Chandrakasan et al.•ARTICLE•Children•2022

    Introduction: Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that is associated with significant morbidity and mortality. SLE disproportionately affects women and minorities. Childhood-onset SLE (cSLE) in particular tends to be more aggressive than adult-onset SLE. Despite substantial improvements in the treatment of cSLE, there is significant variability in treatment responses and long-term outcomes. Furthermore, there is…

  • Improving Hepatitis B Screening Prior to Rituximab

    Open Access•D Sofia Villacis-Nunez, Evan Orenstein et al.•ARTICLE•Children•2023

    Rituximab, used in the treatment of some rheumatic and kidney diseases, can lead to hepatitis B virus (HBV) reactivation; HBV screening is recommended for those starting this medication. We aimed to improve by 50% the proportion of patients undergoing HBV screening by implementing multimodal interventions to support clinicians in this evidence-based practice. We conducted a quality improvement project from November 2020 to June 2022 at a tertiary…

Immunology (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Pediatrics (2 works) · Age of onset (1 work) · Cohort (1 work) · Disease (1 work) · Epidemiology (1 work) · Family medicine (1 work) · HBsAg (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae